North America Artificial Organs and Bionics market has been estimated at USD 7.33 Billion in 2018 and is projected to reach USD 11.37 Billion by 2023, at a CAGR of 9.2% during the forecast period from 2018 to 2023. Artificial organ and implants are special type of made devices/prosthetics which are implanted in human body, so that it can imitates the function original organ. Medical Bionics is substitute or improvement of other body parts with robotic versions. Medical bionic implants are diverse from artificial organs as they impersonate original function very thoroughly or even do better than it.
The market for Artificial Organs and Bionics is mainly driven due to new and improved technologies, increasing organ failure owing to aging and age-related disorders, increasing accidents and injuries leading to amputations, and rise in number of people awaiting organ transplants. But, the market growth is restrained due to high cost associated with organ transplant procedure and price of medical bionics.
North America market for Artificial Organs and Bionics is segmented based on Product, Technology and Type of fixation. By Products, the market is further sub-segmented into Artificial Organs and Bionics. Artificial Organs segment is further sub-segmented into Artificial Heart, Artificial Kidney, Artificial liver, Artificial pancreas, and Artificial lungs. Bionics segment is further sub-segmented into Vision bionics, Orthopedic bionic, Cardiac Bionics, and Brain bionics. By Technology, the market is further sub-segmented into Electronic bionics and Mechanical bionics. By Type of fixation, the market is further sub-segmented into Implantable and Externally-worn. Cardiac bionics and Brain bionics accounts for the largest share in this market.
Geographically, North America market for Artificial Organs and Bionics is segmented into U.S. and Canada. North America is the biggest market in terms of market share across the globe. The market in North America is highly driven due to increasing population and awareness among the patients and the players regarding healthcare facilities and medical tourism.
Orthofix International N.V., Biomet, Inc., Medtronic, Inc., Cochlear Ltd., Second Sight Medical Products, Inc., Ossur, Ekso Bionics, St. Jude Medical, Inc., Baxter International, Inc., Abiomed Inc., Asahi Kasei Medical Co., Ltd, Berlin Heart GmbH, Boston Scientific Corporation, F Hoffman-La Roche Ltd, Worldheart Corporation, Thoratec Corporation, Gambro AB, Lifenet Health, Jarvik Heart Inc. are the major players of North America Artificial Organs and Bionics market.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Artificial Organs
5.1.2.1 Artificial Heart
5.1.2.2 Artificial Kidney
5.1.2.3 Artificial liver
5.1.2.4 Artificial pancreas
5.1.2.5 Artificial lungs
5.1.3 Bionics
5.1.3.1 Vision bionics
5.1.3.2 Ear bionics
5.1.3.3 Orthopedic bionic
5.1.3.4 Cardiac Bionics
5.1.3.5 Brain bionics
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Technology
5.2.1 Introduction
5.2.2 Electronic bionics
5.2.3 Mechanical bionics
5.2.4 Y-o-Y Growth Analysis, By Technology
5.2.5 Market Attractiveness Analysis, By Technology
5.2.6 Market Share Analysis, By Technology
5.3 Type of fixation
5.3.1 Introduction
5.3.2 Implantable
5.3.3 Externally worn
5.3.4 Y-o-Y Growth Analysis, By Type of fixation
5.3.5 Market Attractiveness Analysis, By Type of fixation
5.3.6 Market Share Analysis, By Type of fixation
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technology
6.1.3.4 By Type of fixation
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technology
6.1.4.4 By Type of fixation
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technology
6.1.5.4 By Type of fixation
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Orthofix International N.V.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Biomet, Inc.
8.3 Medtronic, Inc.
8.4 Cochlear Ltd.
8.5 Second Sight Medical Products, Inc.
8.6 Ossur
8.7 Ekso Bionics
8.8 St. Jude Medical, Inc.
8.9 Baxter International, Inc.
8.10 Abiomed Inc.
8.11 Asahi Kasei Medical Co., Ltd
8.12 Berlin Heart GmbH
8.13 Boston Scientific Corporation
8.14 F Hoffman-La Roche Ltd
8.15 Worldheart Corporation
8.16 Thoratec Corporation
8.17 Gambro AB
8.18 Lifenet Health
8.19 Jarvik Heart Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
